One-year prevalence of migraine in Spain: A nationwide population-based survey

Cephalalgia

Volumn 31, Issue 4, 2011, Pages 463-470

  Matías Guiu, Jorge ^a   Porta Etessam, Jesus ^a   Mateos, Valentín ^b   Díaz Insa, Samuel ^c   Lopez Gil, Arturo ^d   Fernández, Cristina ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Medical Center of Asturias   (Spain)

^c Hospital Francesc de Borja   (Spain)

^d Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

cross sectional studies; Migraine disorders epidemiology; prevalence; telephone interviews

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); GEOGRAPHY; HABITAT; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE AURA; MIGRAINE WITH AURA; POPULATION BASED CASE CONTROL STUDY; SPAIN; TELECONSULTATION; ADOLESCENT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; METHODOLOGY; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POPULATION SURVEILLANCE; PREVALENCE; REPRODUCIBILITY OF RESULTS; SPAIN; YOUNG ADULT;

EID: 84855541837     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410382794     Document Type: Article

References (48)

1. Lipton RB, Stewart WF and Scher AI Epidemiology and economic impact of migraine. Curr Med Res Opin 2001 ; 17 (Suppl 1). S4 - S12.
2. Rasmussen BK Epidemiology of headache. Cephalalgia 1995 ; 15: 45-68.
3. Bigal ME, Lipton RB and Stewart WF The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 2004 ; 4: 98-104. (Pubitemid 38899060)
4. Elston Lafata J., Moon C., Leotta C., Kolodner K., Poisson L. and Lipton RB The medical care utilization and costs associated with migraine headache. J Gen Intern Med 2004 ; 19: 1005-112.
5. Goldberg LD The cost of migraine and its treatment. Am J Manag Care 2005 ; 11: S62 - S67.
6. Badia X., Magaz S., Gutiérrez L. and Galván J. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics 2004 ; 22: 591-603. (Pubitemid 38943104)
7. Sheffiled RE Migraine prevalence: literature review. Headache 1998 ; 38: 595-601.
8. Stewart WF, Simon D., Shechter A. and Lipton RB Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol 1995 ; 48: 269-280.
9. Stewart WF, Shechter A. and Rasmussen BK Migraine prevalence. A review of population-based studies. Neurology 1994 ; 44 (6Suppl4): S17 - S23.
10. Natoli J., Manack A., Dean B., et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2009 ; 29: 1468-2982.
11. Leonardi M., Steiner TJ, Scher AT and Lipton RB The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain 2005 ; 6: 429-440. (Pubitemid 43078769)
12. Pfaffenrath V., Fendrich K., Vennemann M., et al. Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia 2009 ; 29: 48-57.
13. Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8: 19-28.
14. Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004 ; 24 (Suppl 1): 9-160.
15. InstitutoNacionaldeEstadica[Spain.]INebase:society/standard/quality and conditions of life, http://www.ine.es/en/inebmenu/mnu-nivel-vida-en.htm ( 2004, accessed July 2010.
16. Lipton RB, Scher AI, Kolodner K., Liberman J., Steiner TJ and Stewart WF Migraine in the United States. Epidemiology and patterns of health care use. Neurology 2002 ; 58: 885-894. (Pubitemid 34242063)
17. Porta J., López-Gil A., Matías-Guiu J. and Fernández C. [Validation of a diagnostic questionnaire for migraine adapted for a computed assisted telephone interviewing.] [Spanish.]. Neurologia 2010 ; 25: 163-167.
18. Instituto Nacional de Estadica [Spain.] INebase: demography and population: census January 1, 2005, http://www.ine.es/en/welcome-en.htm ( 2005, accessed July 2010 ).
19. Láinez J., Vioque J., Hernández Y. and Titus F. Prevalence of migraine in Spain: an assessment of questionnaire's validity by clinical interview. In: Olesen J (ed.) Headache classification and epidemiology. New York: Raven Press, 1994, pp. 221-225.
20. Montiel I., Muñiz R., Asensio M., et al. [Prevalence of migraine in a homogeneous population using the self-questionnaire 'Alcoi-1995'.] [Spanish.]. Rev Neurol 1997 ; 25: 1177-1180. (Pubitemid 27359436)
21. Sánchez-Pérez R., Asensio M., Melchor A., et al. [A descriptive study of migraine in a rural population of Area del Comtat.] [Spanish.]. Rev Neurol 1999 ; 28: 373-376. (Pubitemid 29364374)
22. Stovner LJ, Swart J. -A, Hagen K., Terwindt GM and Pascual J. Epidemiology of headache in Europe. Eur J Neurol 2006 ; 13: 333-345.
23. Dahlöf C. and Linde M. One-year prevalence of migraine in Sweden: a population-based study. Cephalalgia 2001 ; 21: 664-671. (Pubitemid 32762789)
24. Radtke A. and Neuhauser H. Prevalence and burden of headache and migraine in Germany. Headache 2009 ; 49: 79-89.
25. Lampl C., Buzath A., Baumhackl U. and Klingler D. One-year prevalence of migraine in Austria: a nationwide survey. Cephalalgia 2003 ; 23: 280-286. (Pubitemid 36577946)
26. Henry P., Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology 2002 ; 59: 232-237. (Pubitemid 34779183)
27. Zivadinov R., Willheim K., Jurjevic A., Sepic-Grahovac D., Bucuk M. and Zorzon M. Prevalence of migraine in Croatia: a population-based survey. Headache 2001 ; 41: 805-812. (Pubitemid 32953333)
28. Lipton RB, Stewart WF, Diamond S., Diamond ML and Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 ; 41: 646-657. (Pubitemid 32777747)
29. Stewart WF, Shechter A. and Rasmussen BK Variation in migraine prevalence by race. Neurology 1996 ; 47: 52-59. (Pubitemid 26243858)
30. Lipton RB and Stewart WF Prevalence and impact of migraine. Neurol Clin 1997 ; 15: 1-13. (Pubitemid 27098696)
31. Tepper SJ A pivotal moment in 50 years of headache history: the first American Migraine Study. Headache 2008 ; 48: 730-732.
32. Lipton RB and Bigal ME Migraine: epidemiology, impact, and risk factors for progression. Headache 2005 ; 45 (Suppl 1). S3 - S13.
33. Houinato D., Adoukonou T., Ntsiba F., Adjien C., Avode DG and Preux PM Prevalence of migraine in a rural community in south Benin. Cephalalgia 2010 ; 30: 62-67.
34. Stewart WF, Lipton RB and Liberman J. Variation in migraine prevalence by race. Neurology 1996 ; 47: 52-59. (Pubitemid 26243858)
35. Wang SJ, Fuh JL, Young YH, Lu SR and Shia BC Prevalence of migraine in Taipei, Taiwan: a population-based survey. Cephalalgia 2000 ; 20: 566-572.
36. Linde M. and Dahlöf C. Attitudes and burden of disease among self-considered migraineurs-a nation-wide population-based survey in Sweden. Cephalalgia 2004 ; 24: 455-465. (Pubitemid 38748027)
37. Lantéri-Minet M., Valade D., Géraud G., Chautard MH and Lucas C. Migraine and probable migraine-results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 2005 ; 25: 1146-1158. (Pubitemid 41774861)
38. Bigal ME, Liberman JN and Lipton RB Age-dependent prevalence and clinical features of migraine. Neurology 2006 ; 67: 246-251. (Pubitemid 44305407)
39. Bigal ME, Kolodner KB, Lafata JE, Leotta C. and Lipton RB Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan. Cephalalgia 2006 ; 26: 43-49.
40. Lipton RB, Bigal ME, Kolodner K., Stewart WF, Liberman JN and Steiner TJ The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003 ; 23: 429-440. (Pubitemid 36776059)
41. Cevoli S., D'Amico D., Martelletti P., et al. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 2009 ; 29: 1285-1293.
42. MacGregor EA, Brandes J. and Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003 ; 43: 19-26. (Pubitemid 36150986)
43. Brandes JL Global trends in migraine care: results from the MAZE survey. CNS Drugs 2006 ; 16 (Suppl 1). 13-18.
44. Català E., Reig E., Artés M., Aliaga L., López JS and Segú JL Prevalence of pain in the Spanish population: telephone survey in 5000 homes. Eur J Pain 2002 ; 6: 133-140.
45. Lipson RB, Bigal ME, Diamond M., Freitag F., Reed ML and Stewart WF Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 ; 68: 343-349. (Pubitemid 46184209)
46. Kirchmann M. Migraine with aura: new understanding from clinical epidemiologic studies. Curr Opin Neurol 2006 ; 19: 286-293. (Pubitemid 43804685)
47. Vincent MB and Hadjikhani N. Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia 2007 ; 27: 1368-1377. (Pubitemid 350150796)
48. Téllez-Zenteno JF, García-Ramos G., Zermeño- Pöhls F. and Velazquez A. Demographic, clinical and comorbidity data in a large sample of 1147 patients with migraine in Mexico City. J Headache Pain 2005 ; 6: 128-134. (Pubitemid 40916527)